Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.

@article{MoroSibilot2015OutcomesAR,
  title={Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.},
  author={Denis Moro-Sibilot and Egbert F. Smit and Javier de Castro Carpe{\~n}o and Krzysztof Leśniewski-Kmak and Joachim G.J.V. Aerts and Rosa Villatoro and Kees Kraaij and Karim Nacerddine and Yulia Dyachkova and Karen T. Smith and Kaisa Taipale and Allicia C. Girvan and Carla M Visseren-Grul and Philipp Albert Schnabel},
  journal={Lung cancer},
  year={2015},
  volume={88 2},
  pages={
          215-22
        }
}
INTRODUCTION FRAME was a prospective observational study that captured real-world data on patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving platinum-based chemotherapies as first-line treatment (FLT) across Europe. As previously reported, most patients observed in the study had initiated FLT with either pemetrexed, gemcitabine, vinorelbine or taxanes in combination with a platinum. Baseline patient and disease characteristics including age, performance status… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS